These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37878899)

  • 21. [Effect of anticancer treatment on leptin level, fat body mass (FM) and lean body mass (LBM)].
    Krawczyk-Rybak M; Muszyńska-Rosłan K; Konstantynowicz J; Solarz E; Wołczynski S; Protas P
    Med Wieku Rozwoj; 2004; 8(2 Pt 1):297-307. PubMed ID: 15738606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parental functioning during maintenance treatment for childhood acute lymphoblastic leukemia: Effects of treatment intensity and dexamethasone pulses.
    Rensen N; Steur LMH; Grootenhuis MA; van Eijkelenburg NKA; van der Sluis IM; Dors N; van den Bos C; Tissing WJE; Kaspers GJL; van Litsenburg RRL
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28697. PubMed ID: 32909677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study protocol: DexaDays-2, hydrocortisone for treatment of dexamethasone-induced neurobehavioral side effects in pediatric leukemia patients: a double-blind placebo controlled randomized intervention study with cross-over design.
    van Hulst AM; Verwaaijen EJ; Fiocco MF; Pluijm SMF; Grootenhuis MA; Pieters R; van den Akker ELT; van den Heuvel-Eibrink MM
    BMC Pediatr; 2021 Sep; 21(1):427. PubMed ID: 34579671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulse therapy with vincristine and dexamethasone for childhood acute lymphoblastic leukaemia (CCCG-ALL-2015): an open-label, multicentre, randomised, phase 3, non-inferiority trial.
    Yang W; Cai J; Shen S; Gao J; Yu J; Hu S; Jiang H; Fang Y; Liang C; Ju X; Wu X; Zhai X; Tian X; Wang N; Liu A; Jiang H; Jin R; Sun L; Yang M; Leung AWK; Pan K; Zhang Y; Chen J; Zhu Y; Zhang H; Li C; Yang JJ; Cheng C; Li CK; Tang J; Zhu X; Pui CH
    Lancet Oncol; 2021 Sep; 22(9):1322-1332. PubMed ID: 34329606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impaired sleep affects quality of life in children during maintenance treatment for acute lymphoblastic leukemia: an exploratory study.
    van Litsenburg RR; Huisman J; Hoogerbrugge PM; Egeler RM; Kaspers GJ; Gemke RJ
    Health Qual Life Outcomes; 2011 Apr; 9():25. PubMed ID: 21496357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High prevalence of parent-reported sleep problems in pediatric patients with acute lymphoblastic leukemia after induction therapy.
    Steur LMH; Grootenhuis MA; Van Someren EJW; Van Eijkelenburg NKA; Van der Sluis IM; Dors N; Van den Bos C; Tissing WJE; Kaspers GJL; Van Litsenburg RRL
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28165. PubMed ID: 31944548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sleep habits and fatigue of children receiving maintenance chemotherapy for ALL and their parents.
    Zupanec S; Jones H; Stremler R
    J Pediatr Oncol Nurs; 2010; 27(4):217-28. PubMed ID: 20562390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in body mass index in long-term survivors of childhood acute lymphoblastic leukemia treated without cranial radiation and with reduced glucocorticoid therapy.
    Touyz LM; Cohen J; Neville KA; Wakefield CE; Garnett SP; Mallitt KA; Grech AM; Cohn RJ
    Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27862918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations between Metabolic Risk Factors and the Hypothalamic Volume in Childhood Leukemia Survivors Treated with Cranial Radiotherapy.
    Follin C; Gabery S; Petersén Å; Sundgren PC; Björkman-Burtcher I; Lätt J; Mannfolk P; Erfurth EM
    PLoS One; 2016; 11(1):e0147575. PubMed ID: 26824435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does dexamethasone induce more neuropsychological side effects than prednisone in pediatric acute lymphoblastic leukemia? A systematic review.
    Warris LT; van den Heuvel-Eibrink MM; den Hoed MA; Aarsen FK; Pieters R; van den Akker EL
    Pediatr Blood Cancer; 2014 Jul; 61(7):1313-8. PubMed ID: 24532490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Degree of fatness after treatment for acute lymphoblastic leukemia in childhood.
    Nysom K; Holm K; Michaelsen KF; Hertz H; Müller J; Mølgaard C
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4591-6. PubMed ID: 10599724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dexamethasone compared to prednisolone for adults with acute lymphoblastic leukemia or lymphoblastic lymphoma: final results of the ALL-4 randomized, phase III trial of the EORTC Leukemia Group.
    Labar B; Suciu S; Willemze R; Muus P; Marie JP; Fillet G; Berneman Z; Jaksic B; Feremans W; Bron D; Sinnige H; Mistrik M; Vreugdenhil G; De Bock R; Nemet D; Gilotay C; Amadori S; de Witte T;
    Haematologica; 2010 Sep; 95(9):1489-95. PubMed ID: 20378563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in body mass index, height, and weight in children during and after therapy for acute lymphoblastic leukemia.
    Browne EK; Zhou Y; Chemaitilly W; Panetta JC; Ness KK; Kaste SC; Cheng C; Relling MV; Pui CH; Inaba H
    Cancer; 2018 Nov; 124(21):4248-4259. PubMed ID: 30358906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
    Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
    Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antileukemic Efficacy of Continuous vs Discontinuous Dexamethasone in Murine Models of Acute Lymphoblastic Leukemia.
    Ramsey LB; Janke LJ; Payton MA; Cai X; Paugh SW; Karol SE; Kamdem Kamdem L; Cheng C; Williams RT; Jeha S; Pui CH; Evans WE; Relling MV
    PLoS One; 2015; 10(8):e0135134. PubMed ID: 26252865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacogenetic risk factors for altered bone mineral density and body composition in pediatric acute lymphoblastic leukemia.
    te Winkel ML; van Beek RD; de Muinck Keizer-Schrama SM; Uitterlinden AG; Hop WC; Pieters R; van den Heuvel-Eibrink MM
    Haematologica; 2010 May; 95(5):752-9. PubMed ID: 20015871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of prednisolone and low dosed dexamethasone exhibits greater in vitro antileukemic activity than equiactive dose of prednisolone and overcomes prednisolone drug resistance in acute childhood lymphoblastic leukemia.
    Spenerova M; Dzubak P; Srovnal J; Radova L; Burianova R; Konecny P; Salkova S; Novak Z; Pospisilova D; Stary J; Blazek B; Hak J; Votava T; Timr P; Kaiserova E; Bubanska E; Mihal V; Hajduch M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Sep; 158(3):422-7. PubMed ID: 23128824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Völkl TM; Simm D; Beier C; Dörr HG
    Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of medium chain triglycerides on body fat distribution and adipocytokine levels in children with acute lymphoblastic leukemia under chemotherapy.
    Zhang R; Chen J; Zheng H; Li Y; Huang H; Liang Z; Jiang H; Sun J
    Medicine (Baltimore); 2019 Aug; 98(33):e16811. PubMed ID: 31415396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro susceptibility to dexamethasone- and doxorubicin-induced apoptotic cell death in context of maturation stage, responsiveness to interleukin 7, and early cytoreduction in vivo in childhood T-cell acute lymphoblastic leukemia.
    Wuchter C; Ruppert V; Schrappe M; Dörken B; Ludwig WD; Karawajew L
    Blood; 2002 Jun; 99(11):4109-15. PubMed ID: 12010814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.